ATAI
Price
$1.47
Change
+$0.05 (+3.52%)
Updated
Apr 17 closing price
Capitalization
291.51M
31 days until earnings call
LTRN
Price
$3.42
Change
-$0.07 (-2.01%)
Updated
Apr 17 closing price
Capitalization
36.88M
17 days until earnings call
Ad is loading...

ATAI vs LTRN

Header iconATAI vs LTRN Comparison
Open Charts ATAI vs LTRNBanner chart's image
ATAI Life Sciences
Price$1.47
Change+$0.05 (+3.52%)
Volume$1.66M
Capitalization291.51M
Lantern Pharma
Price$3.42
Change-$0.07 (-2.01%)
Volume$8.12K
Capitalization36.88M
ATAI vs LTRN Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. LTRN commentary
Apr 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Buy and LTRN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 19, 2025
Stock price -- (ATAI: $1.47 vs. LTRN: $3.42)
Brand notoriety: ATAI and LTRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 64% vs. LTRN: 19%
Market capitalization -- ATAI: $291.51M vs. LTRN: $36.88M
ATAI [@Biotechnology] is valued at $291.51M. LTRN’s [@Biotechnology] market capitalization is $36.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $282.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileLTRN’s FA Score has 1 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • LTRN’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATAI and LTRN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 3 TA indicator(s) are bullish while LTRN’s TA Score has 5 bullish TA indicator(s).

  • ATAI’s TA Score: 3 bullish, 4 bearish.
  • LTRN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, LTRN is a better buy in the short-term than ATAI.

Price Growth

ATAI (@Biotechnology) experienced а +21.49% price change this week, while LTRN (@Biotechnology) price change was +12.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.03%. For the same industry, the average monthly price growth was -13.25%, and the average quarterly price growth was -24.49%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

LTRN is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (+7.03% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($292M) has a higher market cap than LTRN($36.9M). ATAI YTD gains are higher at: 10.526 vs. LTRN (7.210). LTRN has higher annual earnings (EBITDA): -21.18M vs. ATAI (-144.81M). ATAI has more cash in the bank: 62.3M vs. LTRN (28.1M). LTRN has less debt than ATAI: LTRN (291K) vs ATAI (24.7M). ATAI has higher revenues than LTRN: ATAI (308K) vs LTRN (0).
ATAILTRNATAI / LTRN
Capitalization292M36.9M791%
EBITDA-144.81M-21.18M684%
Gain YTD10.5267.210146%
P/E RatioN/AN/A-
Revenue308K0-
Total Cash62.3M28.1M222%
Total Debt24.7M291K8,488%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
12
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAILTRN
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME26.780.53
+2.02%
GameStop Corp
AAPL196.982.71
+1.39%
Apple
BTC.X84895.750000861.882800
+1.03%
Bitcoin cryptocurrency
SPY526.410.75
+0.14%
SPDR® S&P 500® ETF
TSLA241.37-0.18
-0.07%
Tesla

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
+3.52%
MNMD - ATAI
51%
Loosely correlated
+5.68%
CRSP - ATAI
47%
Loosely correlated
-0.03%
RXRX - ATAI
47%
Loosely correlated
+3.38%
RCKT - ATAI
46%
Loosely correlated
+2.93%
NTLA - ATAI
45%
Loosely correlated
+5.39%
More

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with ABCL. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then ABCL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
-2.01%
ABCL - LTRN
38%
Loosely correlated
+1.26%
ABSI - LTRN
38%
Loosely correlated
+1.31%
ATAI - LTRN
37%
Loosely correlated
+3.52%
IMNM - LTRN
37%
Loosely correlated
+10.32%
CRSP - LTRN
37%
Loosely correlated
-0.03%
More